| Identification | Back Directory | [Name]
Sitagliptin Defuoro IMpurity 3 | [CAS]
851307-12-5 | [Synonyms]
Sitagliptin iMpurity L
Sitagliptin Defuoro IMpurity 3
Sitagliptin Defluoro Impurity 3
(R)-Sitagliptin Defluoro Impurity
(R)-Sitagliptin Defluoro Impurity 3
(R)-b-(Boc-amino)-2,4-difluorobenzenebutanoic acid
Boc-(R)-3-Amino-4-(2,4-difluorophenyl)-butyricacid
Sitagliptin Defluoro Impurity 3 (Sitagliptin impurity I)
Sitagliptin defluorinated impurity 3 (sitagliptin impurity I)
3-TERT-BUTOXYCARBONYLAMINO-4-(2,4-DIFLUORO-PHENYL)-BUTYRIC ACID
(R)-3-(tert-butoxycarbonylaMino)-4-(2,4-difluorophenyl)butanoic acid
3-([(tert-Butoxy)carbonyl]amino)-4-(2,4-difluorophenyl)butanoic acid
(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid
Benzenebutanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-2,4-difluoro-, (βR)-
(3R)-4-(2,4-difluorophenyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
Sitagliptin impurity 16/(R)-Sitagliptin Defluoro Impurity 3/(R)-b-(Boc-amino)-2,4-difluorobenzenebutanoic acid | [Molecular Formula]
C15H19F2NO4 | [MDL Number]
MFCD27951984 | [MOL File]
851307-12-5.mol | [Molecular Weight]
315.31 |
| Chemical Properties | Back Directory | [Boiling point ]
444.3±45.0 °C(Predicted) | [density ]
1.243±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [pka]
4.37±0.10(Predicted) | [Appearance]
white solid | [InChI]
InChI=1/C15H19F2NO4/c1-15(2,3)22-14(21)18-11(8-13(19)20)6-9-4-5-10(16)7-12(9)17/h4-5,7,11H,6,8H2,1-3H3,(H,18,21)(H,19,20)/t11-/s3 | [InChIKey]
LUYHWLQWAVCDNA-LBPXTSNRNA-N | [SMILES]
C(O)(=O)C[C@H](NC(OC(C)(C)C)=O)CC1=CC=C(F)C=C1F |&1:4,r| |
| Hazard Information | Back Directory | [Uses]
(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic Acid is a derivative of Sitagliptin (S491000), a dipeptidyl peptidase-4 inhibitor used to treat patients with type-2 diabetes by means of glycemic control. |
|
| Company Name: |
TOSUN PHARM
|
| Telephone: |
020-66392521-118 18922260391 |
| Website: |
www.toref.cn/ |
|